Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Montevialeon Oct 02, 2017 8:41pm
175 Views
Post# 26768796

ACMPR Amendments - Re Pharmacy Distribution

ACMPR Amendments - Re Pharmacy DistributionThe Access to Cannabis for Medical Purposes Regulations (ACMPR) came into force on August 24, 2016.  According to Health Canada, the ACMPR is not a long term plan but a temporary fix to address issues with the MMPR.  Therefore we know changes are coming.  

In the next go around, changes to the existing ACMPR are expected to include pharmacy distribution.  

Most likely, Health Canada is deliberately stalling the amendment of ACMPR until licensed  producers can guarantee a consistent supply of medical cannabis for patients.  

From a timing perspective, spring of 2018 would be perfect timing for the Federal government to introduce amendments to the ACMPR allowing pharmacies to become part of the distribution channel.  This would coincide with Aphria's first full crop rotation from Phase III expansion scheduled for May 2018.  Before completion of Phase III it would be unrealistic to expect Aphria to be in a position to service / supply pharmacies.  

Curious to hear if anyone else has an opinion as to when pharmacies will become part of the distribution channel for the medical market.     

M








Bullboard Posts